NCT06360627Recruiting
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Source: ClinicalTrials.gov · Last updated 11 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 27 Feb 2023
- Start date
- 20 Feb 2023
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- University of Zurich
- Diseases
- Lung cancer
- NCT number
- NCT06360627
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 20 Feb 2023 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- under 18
- BMI over 30
Who the study is looking for
- CT SCAN for pulmonary nodule detection/follow up
- CT SCAN for pneumonia detection/follow up
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Zurich - Diagnostic Radiology Coordinator of this site? Confirm its status | Zurich | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.